CALC
Price
$3.11
Change
-$0.23 (-6.89%)
Updated
Nov 13, 04:03 PM (EDT)
Capitalization
46.67M
Intraday BUY SELL Signals
PRRUF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
259.68M
Intraday BUY SELL Signals
Interact to see
Advertisement

CALC vs PRRUF

Header iconCALC vs PRRUF Comparison
Open Charts CALC vs PRRUFBanner chart's image
CalciMedica
Price$3.11
Change-$0.23 (-6.89%)
Volume$217
Capitalization46.67M
Immutep
PriceLoading...
Change-$0.00 (-0.00%)
Volume$3K
Capitalization259.68M
CALC vs PRRUF Comparison Chart in %
CALC
Daily Signal:
Gain/Loss:
PRRUF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CALC vs. PRRUF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Hold and PRRUF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CALC: $3.34 vs. PRRUF: $0.20)
Brand notoriety: CALC and PRRUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 70% vs. PRRUF: 200%
Market capitalization -- CALC: $46.67M vs. PRRUF: $259.68M
CALC [@Biotechnology] is valued at $46.67M. PRRUF’s [@Biotechnology] market capitalization is $259.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 1 FA rating(s) are green whilePRRUF’s FA Score has 0 green FA rating(s).

  • CALC’s FA Score: 1 green, 4 red.
  • PRRUF’s FA Score: 0 green, 5 red.
According to our system of comparison, CALC is a better buy in the long-term than PRRUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 5 TA indicator(s) are bullish while PRRUF’s TA Score has 3 bullish TA indicator(s).

  • CALC’s TA Score: 5 bullish, 4 bearish.
  • PRRUF’s TA Score: 3 bullish, 0 bearish.
According to our system of comparison, PRRUF is a better buy in the short-term than CALC.

Price Growth

CALC (@Biotechnology) experienced а +12.46% price change this week, while PRRUF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRRUF($260M) has a higher market cap than CALC($46.7M). PRRUF YTD gains are higher at: -1.079 vs. CALC (-5.650). CALC has higher annual earnings (EBITDA): -30.55M vs. PRRUF (-43.83M). PRRUF has more cash in the bank: 159M vs. CALC (18M). PRRUF has less debt than CALC: PRRUF (1.69M) vs CALC (8.5M). CALC (0) and PRRUF (0) have equivalent revenues.
CALCPRRUFCALC / PRRUF
Capitalization46.7M260M18%
EBITDA-30.55M-43.83M70%
Gain YTD-5.650-1.079524%
P/E Ratio0.30N/A-
Revenue00-
Total Cash18M159M11%
Total Debt8.5M1.69M504%
FUNDAMENTALS RATINGS
PRRUF: Fundamental Ratings
PRRUF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CALCPRRUF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
CALC
Daily Signal:
Gain/Loss:
PRRUF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CERS1.65N/A
N/A
Cerus Corp
LSMNF19.92N/A
N/A
Lastminute.com NV
IOOFF1.30N/A
N/A
Insignia Financial Ltd.
HDALF1.72N/A
N/A
Haidilao International Hldg Ltd
TELA1.14-0.05
-4.20%
TELA Bio

CALC and

Correlation & Price change

A.I.dvisor tells us that CALC and OBIO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALC and OBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
+4.05%
OBIO - CALC
33%
Poorly correlated
+7.80%
MTNB - CALC
28%
Poorly correlated
+5.83%
ABOS - CALC
26%
Poorly correlated
-1.02%
ALDX - CALC
26%
Poorly correlated
+1.34%
VTYX - CALC
26%
Poorly correlated
+0.85%
More

PRRUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRRUF has been loosely correlated with IMMP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRRUF jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRRUF
1D Price
Change %
PRRUF100%
N/A
IMMP - PRRUF
43%
Loosely correlated
+0.56%
CALC - PRRUF
24%
Poorly correlated
+4.05%
PHGUF - PRRUF
21%
Poorly correlated
N/A
PVCT - PRRUF
11%
Poorly correlated
+5.45%
OXBDF - PRRUF
9%
Poorly correlated
N/A
More